EP2176256A2
Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases
Abstract
This record has no abstract on file.
Term
Projected expiry 8 July 2028.
- Priority
- Filed
- Published
- Today
- Projected expiry
Every citation, both ways
| Reference | Relation | Cited during |
|---|---|---|
| See references of WO 2009007751A3 | Non-patent | Search report |
22 members in 17 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 948570P | United States of America | – | |
| 94857007 | United States of America | P | |
| 2008050549 | United Kingdom | W |
Members22
| Document | Office | Kind | |
|---|---|---|---|
| US2008088756A1 | United States of America | A1 | |
| US2008252556A1 | United States of America | A1 | |
| AU2008273892A1 | Australia | A1 | |
| CA2692725A1 | Canada | A1 | |
| WO2009007751A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2009007751A3 | World Intellectual Property Organization (WIPO) | A3 | |
| DOP2010000013A | Dominican Republic | A | |
| ECSP109934A | Ecuador | A | |
| EP2176256A2This record | European Patent Office (EPO) | A2 | |
| KR20100042643A | Republic of Korea | A | |
| US7724347B2 | United States of America | B2 | |
| SV2010003451A | El Salvador | A | |
| CR11199A | Costa Rica | A | |
| EA201000090A1 | Eurasian Patent Organization (EAPO) | A1 | |
| CN101801963A | China | A | |
| US2010227858A1 | United States of America | A1 | |
| NI201000003A | Nicaragua | A | |
| JP2010533161A | Japan | A | |
| CO6251271A2 | Colombia | A2 | |
| ZA201000087B | South Africa | B | |
| US8100539B2 | United States of America | B2 | |
| BRPI0814503A2 | Brazil | A2 |
8 legal events, as 2 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Applications withdrawn, deemed to be withdrawn, or refused after publication in hong kongWithdrawnWD | WD | HK | |
| Application deemed to be withdrawnWithdrawn18D | 18D | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWNSTAA | STAA | EP | |
| Requests to designate patent in hong kongDE | DE | HK | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Request for extension of the european patentAX | AX | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 2176256
- Application
- 87761847
Titles3
- German
- TRISUBSTITUIERTE PYRIMIDINDERIVATE ZUR BEHANDLUNG PROLIFERATIVER KRANKHEITEN
- English
- TRISUBSTITUTED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES
- French
- DERIVES DE PYRIMIDINE TRISUBSTITUES POUR LE TRAITEMENT DE MALADIES PROLIFERATIVES
Classification
- CPC, 10
- C07D471/04
- A61P9/00
- A61P11/00
- A61P29/00
- A61P35/00
- A61P37/00
- A61P37/08
- A61P43/00
- C07D413/14
- C07D417/14
- IPC, 5
- C07D413 14
- A61K31 5377
- A61P35 00
- C07D417 14
- C07D471 04
Designated states38
- Contracting states, 34
- Austria
- Belgium
- Bulgaria
- Switzerland
- Cyprus
- Czechia
- Germany
- Denmark
- Estonia
- Spain
- Finland
- France
- United Kingdom
- Greece
- Croatia
- Hungary
- Ireland
- Iceland
- Italy
- Liechtenstein
- Lithuania
- Luxembourg
- Latvia
- Monaco
and 10 moreShow fewer
- Malta
- Netherlands (Kingdom of the)
- Norway
- Poland
- Portugal
- Romania
- Sweden
- Slovenia
- Slovakia
- Türkiye
- Extension states, 4
- Albania
- Bosnia and Herzegovina
- North Macedonia
- Serbia